AllianceBernstein’s CytRx Corp CYTR Stock Holding History

AllianceBernstein’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,783	Closed	-$15K	–	3258
2017 Q1	$15K	Hold	5,783	–	–	﹤0.01%	2985
2016 Q4	$13K	Hold	5,783	–	–	﹤0.01%	3010
2016 Q3	$20K	Sell	5,783 -1,617	-22%	-$7.41K	﹤0.01%	2970
2016 Q2	$99K	Buy	7,400 +3,233	+78%	+$53.8K	﹤0.01%	2912
2016 Q1	$67K	Hold	4,167	–	–	﹤0.01%	2861
2015 Q4	$66K	Hold	4,167	–	–	﹤0.01%	2878
2015 Q3	$59K	Hold	4,167	–	–	﹤0.01%	2911
2015 Q2	$93K	Buy	4,167 +1,000	+32%	+$25K	﹤0.01%	2955
2015 Q1	$64K	Sell	3,167 -2,033	-39%	-$37.8K	﹤0.01%	3107
2014 Q4	$85K	Sell	5,200 -1,133	-18%	-$17.7K	﹤0.01%	3024
2014 Q3	$97K	Hold	6,333	–	–	﹤0.01%	2973
2014 Q2	$159K	Buy	+6,333	New	+$144K	﹤0.01%	2885

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AllianceBernstein's CYTR Position: Q2 2017 in Review

AllianceBernstein sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 5,783 shares — an estimated $15K sold.

AllianceBernstein first reported a position in CYTR in Q2 2014 and held it in 12 quarters. The position peaked at $159K in Q2 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

AllianceBernstein reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
AllianceBernstein sold 5,783 CytRx Corp shares in Q2 2017, an estimated $15K.
AllianceBernstein first reported a position in CytRx Corp in Q2 2014 and held it in 12 quarters.
AllianceBernstein's CytRx Corp position peaked at $159K in Q2 2014.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on AllianceBernstein's 13F filing for Q2 2017, filed 10 Aug 2017.